Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.

Transfusion - 1 Sept 2005

Palomäki Pekka, Wessberg Susanna, Tuomi Katri, Laitinen Harri

Abstract excerpt

BACKGROUND: This report describes the validation results and the performance characteristics of a new, semiautomated minipool nucleic acid amplification method for testing of blood products to reduce the transmission of hepatitis C virus (HCV) by transfusions. STUDY DESIGN AND METHODS: Minipools of 96 donations were prepared with the Tecan Genesis pipettors. Nucleic acids were isolated from plasma samples with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Donors
Share to Evaluation Studies as Topic
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Mass Screening

Share to Nucleic Acid Amplification Techniques

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 16131386
DOI: 10.1111/j.1537-2995.2005.00557.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.PMID 16131386Read ↗

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.Semantic proximity Read ↗

Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture.Semantic proximity Read ↗

Evaluation of the MagNA Pure LC used with the TRUGENE HBV Genotyping Kit.Semantic proximity Read ↗

Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.Semantic proximity Read ↗

Performance of Version 2.0 of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA QuantificationSemantic proximity Read ↗

Performances of NeuMoDx, a random-access system for HBV-DNA and HCV-RNA quantificationSemantic proximity Read ↗

Evaluation of the new cobas® HCV genotyping test based on real-time PCRs of three different HCV genome regions.Semantic proximity Read ↗

Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis.Semantic proximity Read ↗

Performance of the COBAS® AmpliPrep/COBAS TaqMan® automated system for hepatitis C virus (HCV) quantification in a multi-center comparison.Semantic proximity Read ↗

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingSemantic proximity Read ↗

Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood.Semantic proximity Read ↗

PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.